Linagliptin, a DPP-4 inhibitor, ameliorates Aβ (1-42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer's disease.

Neuropharmacology
Nazia SiddiquiMohd Akhtar

Abstract

Alzheimer's disease (AD) is the most devastating neurodegenerative disorder, accounting over 46 million cases of dementia globally. Evidence supports that Brain Insulin Resistance (BIR) due to serine phosphorylation of Insulin Receptor Substrate-1 (IRS-1) has an association with AD. GLP-1 an incretin hormone, rapidly degraded by Dipeptidyl Peptidase-4 (DPP-4) has also confirmed its efficacious role in AD. Linagliptin, a DPP-4 inhibitor is hypothesized to increase GLP-1 level, which then crosses Blood Brain Barrier (BBB), decreases Amyloid-beta (Aβ) and insulin resistance in hippocampus. Thus, the present study was designed to evaluate Linagliptin in Aβ (1-42) peptides induced rat model of AD. Following 1 week of induction, rats were administered with Linagliptin (0.513 mg/kg, 3 mg/kg, and 5 mg/kg) orally for 8 weeks and donepezil (5 mg/kg) as a reference standard. At the end of scheduled treatment neurobehavioral parameters were assessed. After this, rats were sacrificed, hippocampus was isolated from the whole brain for histopathological analysis and biochemical parameters estimation. Linagliptin dose-dependently and significantly reversed motor and cognitive impairment, assessed through locomotor activity (LA) and Morris wate...Continue Reading

References

Jun 1, 1966·The Biochemical Journal·E D Wills
Apr 5, 2002·Journal of Molecular Neuroscience : MN·Abba J KastinWeihong Pan
Jul 1, 1961·Biochemical Pharmacology·G L ELLMANR M FEATHER-STONE
Feb 26, 2004·Lancet Neurology·Suzanne Craft, G Stennis Watson
Feb 18, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jenny NybergPeter S Eriksson
Jul 22, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Daniela PuzzoOttavio Arancio
Dec 21, 2006·Nature Reviews. Neuroscience·Michelle L BlockJau-Shyong Hong
Sep 29, 2009·Experimental Neurology·Félix HernándezJesús Avila
Nov 4, 2009·Journal of Diabetes Science and Technology·Suzanne M de la Monte, Jack R Wands
Apr 3, 2010·Neurobiology of Aging·Simon GenglerChristian Hölscher
Jul 16, 2010·Journal of Neural Transmission·Michael T HenekaMarkus Peter Kummer
Mar 26, 2011·Journal of Cellular and Molecular Medicine·Domenico BoscoArturo Pujia
Nov 26, 2011·European Journal of Pharmacology·Emilie FaivreChristian Hölscher
Jan 10, 2012·Cold Spring Harbor Perspectives in Medicine·Alberto Serrano-PozoBradley T Hyman
Sep 11, 2012·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Mary D NaylorJohn Q Trojanowski
Oct 2, 2012·Journal of Neuroimmunology·Shivika RaiRakesh Shukla
Mar 23, 2013·Diabetes·Richard P Shannon
Apr 23, 2013·Neuropharmacology·Jayasankar KosarajuDuraiswamy Basavan
Aug 8, 2013·Future Medicinal Chemistry·Qin Zhihui
Mar 20, 2014·Neurodegenerative Disease Management·Konrad Talbot
May 14, 2014·Regulatory Peptides·Vladimer DarsaliaCesare Patrone
Dec 3, 2014·Neuropharmacology·Noha N NassarDalaal M Abdallah
Jan 30, 2015·Neurochemical Research·Arokiasamy Justin ThenmozhiThamilarasan Manivasagam
Apr 15, 2015·The Journal of Nutritional Biochemistry·Anand Kamal Sachdeva, Kanwaljit Chopra
May 27, 2015·CNS Neuroscience & Therapeutics·Edy KorneliusChien-Ning Huang
Nov 13, 2015·European Journal of Medicinal Chemistry·Mudasir MaqboolNasimul Hoda
Jan 2, 2016·Pharmacological Reports : PR·Justyna GodyńBarbara Malawska
Apr 19, 2016·Chemico-biological Interactions·Michael CostaMaria E Pereira
May 18, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Valeria Calsolaro, Paul Edison
May 18, 2016·Journal of Diabetes Investigation·Kenichi Katsurada, Toshihiko Yada
Oct 8, 2016·Expert Review of Neurotherapeutics·Antonella TramutolaEugenio Barone

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.